N-Q 1 form-141.htm QUARTERLY SCHEDULE form-141.htm - Generated by SEC Publisher for SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM N-Q

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT
INVESTMENT COMPANY

Investment Company Act file number                   811- 3081

Dreyfus Appreciation Fund, Inc.
(Exact name of Registrant as specified in charter)

c/o The Dreyfus Corporation
200 Park Avenue
New York, New York 10166
(Address of principal executive offices) (Zip code)

Michael A. Rosenberg, Esq.
200 Park Avenue
New York, New York 10166
(Name and address of agent for service)

Registrant's telephone number, including area code: (212) 922-6000
Date of fiscal year end: 12/31  
Date of reporting period: 3/31/10  



FORM N-Q

Item 1. Schedule of Investments.



STATEMENT OF INVESTMENTS    
Dreyfus Appreciation Fund, Inc.    
March 31, 2010 (Unaudited)    
 
Common Stocks--99.2% Shares Value ($)
Consumer Discretionary--8.8%    
Christian Dior 293,500 31,309,098
McDonald's 719,700 48,018,384
McGraw-Hill 667,000 23,778,550
News, Cl. A 2,212,308 31,879,358
News, Cl. B 166,900 a 2,838,969
Target 469,100 24,674,660
    162,499,019
Consumer Staples--34.2%    
Altria Group 2,373,700 48,708,324
Coca-Cola 1,595,000 87,725,000
Estee Lauder, Cl. A 322,900 a 20,946,523
Fomento Economico Mexicano, ADR 185,500 8,816,815
Kraft Foods, Cl. A 350,568 10,601,176
Nestle, ADR 1,921,150 98,362,880
PepsiCo 679,300 44,942,488
Philip Morris International 2,373,700 123,812,192
Procter & Gamble 1,367,300 86,509,071
SYSCO 434,100 12,805,950
Wal-Mart Stores 689,100 38,313,960
Walgreen 1,272,200 47,185,898
Whole Foods Market 157,500 a,b 5,693,625
    634,423,902
Energy--18.6%    
Chevron 822,400 62,362,592
ConocoPhillips 881,700 45,116,589
Exxon Mobil 1,523,598 102,050,594
Halliburton 542,200 16,336,486
Occidental Petroleum 616,600 52,127,364
Royal Dutch Shell, ADR 441,800 25,562,548
Total, ADR 714,900 41,478,498
    345,034,671
Financial--6.2%    
Bank of America 1,046,950 18,688,058
Berkshire Hathaway, Cl. A 322 b 39,219,600
HSBC Holdings, ADR 555,166 a 28,141,365



JPMorgan Chase & Co. 653,400 29,239,650
    115,288,673
Health Care--11.5%    
Abbott Laboratories 861,300 45,373,284
Becton Dickinson & Co. 39,300 3,094,089
Intuitive Surgical 21,200 a,b 7,380,356
Johnson & Johnson 1,265,900 82,536,680
Medtronic 279,500 12,585,885
Merck & Co. 334,000 12,474,900
Novo Nordisk, ADR 258,500 19,935,520
Roche Holding, ADR 758,400 30,730,368
    214,111,082
Industrial--4.9%    
Caterpillar 312,500 a 19,640,625
General Dynamics 74,000 5,712,800
General Electric 1,877,400 34,168,680
McDermott International 168,300 b 4,530,636
United Technologies 376,600 27,721,526
    91,774,267
Information Technology--12.3%    
Apple 264,200 b 62,068,506
Automatic Data Processing 447,800 19,913,666
Cisco Systems 947,100 b 24,653,013
Intel 3,014,500 67,102,770
Microsoft 790,000 23,123,300
QUALCOMM 302,000 12,680,980
Texas Instruments 802,200 19,629,834
    229,172,069
Materials--2.7%    
Freeport-McMoRan Copper & Gold 185,600 a 15,505,024
Praxair 385,100 31,963,300
Rio Tinto, ADR 14,800 3,503,604
    50,971,928
Total Common Stocks    
(cost $1,161,693,508)   1,843,275,611
 
Other Investment--.6%    
Registered Investment Company;    
Dreyfus Institutional Preferred    
     Plus Money Market Fund    
     (cost $10,677,000) 10,677,000 c 10,677,000



Investment of Cash Collateral for    
Securities Loaned--1.4%    
Registered Investment Company;    
Dreyfus Institutional Cash    
Advantage Fund    
(cost $25,810,587) 25,810,587 c 25,810,587
 
Total Investments (cost $1,198,181,095) 101.2% 1,879,763,198
Liabilities, Less Cash and Receivables (1.2%) (22,851,978)
Net Assets 100.0% 1,856,911,220

ADR - American Depository Receipts

a Security, or portion thereof, on loan. At March 31, 2010, the total market value of the fund's securities on loan is
  $25,149,854 and the total market value of the collateral held by the fund is $25,810,587.
b Non-income producing security.
c Investment in affiliated money market mutual fund.

At March 31, 2010, the aggregate cost of investment securities for income tax purposes was $1,198,181,095.

Net unrealized appreciation on investments was $681,582,103 of which $747,314,814 related to appreciated investment securities and $65,732,711 related to depreciated investment securities.



Various inputs are used in determining the value of the fund's investments relating to fair value measurements.

These inputs are summarized in the three broad levels listed below.

Level 1 - unadjusted quoted prices in active markets for identical investments.
Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds,
credit risk, etc.)
Level 3 - significant unobservable inputs (including fund's own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

The following is a summary of the inputs used as of March 31, 2010 in valuing the fund's investments:

      Level 3 -  
  Level 1 - Level 2 - Other Significant  
  Unadjusted Significant Observable Unobservable  
Assets ($) Quoted Prices Inputs Inputs Total
Investments in Securities:        
Equity Securities - Domestic+ 1,555,434,915 - - 1,555,434,915
Equity Securities - Foreign+ 287,840,696 - - 287,840,696
Mutual Funds 36,487,587 - - 36,487,587

+ See Statement of Investments for industry classification.



The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) is the exclusive reference of authoritative U.S. generally accepted accounting principles (“GAAP”) recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the Securities and Exchange Commission (“SEC”) under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund's financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

Portfolio valuation: Investments in securities are valued at the last sales price on the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Market System for which market quotations are available are valued at the official closing price or, if there is no official closing price that day, at the last sales price. Securities not listed on an exchange or the national securities market, or securities for which there were no transactions, are valued at the average of the most recent bid and asked prices. Bid price is used when no asked price is available. Registered investment companies that are not traded on an exchange are valued at their net asset value. When market quotations or official closing prices are not readily available, or are determined not to reflect accurately fair value, such as when the value of a security has been significantly affected by events after the close of the exchange or market on which the security is principally traded (for example, a foreign exchange or market), but before the fund calculates its net asset value, the fund may value these investments at fair value as determined in accordance with the procedures approved by the Board of Directors. Fair valuing of securities may be determined with the assistance of a pricing service using calculations based on indices of domestic securities and other appropriate indicators, such as prices of relevant ADRs and futures contracts. For other securities that are fair valued by the Board of Directors, certain factors may be considered such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. Financial futures are valued at the last sales price. Investments denominated in foreign currencies are translated to U.S. dollars at the prevailing rates of exchange.



Pursuant to a securities lending agreement with The Bank of New York Mellon, a subsidiary of BNY Mellon and an affiliate of Dreyfus, the fund may lend securities to qualified institutions. It is the fund’s policy that, at origination, all loans are secured by collateral of at least 102% of the value of U.S. securities loaned and 105% of the value of foreign securities loaned. Collateral equivalent to at least 100% of the market value of securities on loan is maintained at all times. Collateral is either in the form of cash, which can be invested in certain money market mutual funds managed by the Manager, U.S. Government and Agency securities or letters of credit. The fund is entitled to receive all income on securities loaned, in addition to income earned as a result

of the lending transaction. Although each security loaned is fully collateralized, the fund bears the risk of delay in recovery of, or loss of rights in, the securities loaned should a borrower fail to return the securities in a timely manner.

The fund adopted the provisions of ASC Topic 815 “Derivatives and Hedging” which requires qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of gains and losses on derivative instruments and disclosures about credit-risk-related contingent features in derivative agreements. The fund held no derivatives during the period ended March 31, 2010.These disclosures did not impact the notes to the financial statements.

Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the Securities and Exchange Commission on Form N-CSR.



Item 2. Controls and Procedures.

(a) The Registrant's principal executive and principal financial officers have concluded, based on their evaluation of the Registrant's disclosure controls and procedures as of a date within 90 days of the filing date of this report, that the Registrant's disclosure controls and procedures are reasonably designed to ensure that information required to be disclosed by the Registrant on Form N-Q is recorded, processed, summarized and reported within the required time periods and that information required to be disclosed by the Registrant in the reports that it files or submits on Form N-Q is accumulated and communicated to the Registrant's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

(b) There were no changes to the Registrant's internal control over financial reporting that occurred during the Registrant's most recently ended fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Registrant's internal control over financial reporting.

Item 3. Exhibits.

(a) Certifications of principal executive and principal financial officers as required by Rule 30a-2(a) under the Investment Company Act of 1940.



FORM N-Q

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dreyfus Appreciation Fund, Inc.

By: /s/ Bradley J. Skapyak
  Bradley J. Skapyak
  President
 
Date: May 24, 2010

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

By: /s/ Bradley J. Skapyak
  Bradley J. Skapyak
  President
 
Date: May 24, 2010
 
By: /s/ James Windels
James Windels
  Treasurer
 
Date: May 24, 2010

EXHIBIT INDEX

(a) Certifications of principal executive and principal financial officers as required by Rule 30a-2(a) under the Investment Company Act of 1940. (EX-99.CERT)